March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
December 4, 2023
The University of Cincinnati's Rowena Schwartz joined The Oncology Nursing Podcast to discuss what oncology nurses need to know about a class of drugs called antimetabolites.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
June 21, 2024
University of Cincinnati laryngology researchers are using high-speed camera technology to learn more about the physiology of voice and swallowing and improve patient outcomes.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
February 7, 2022
The Journal-News featured the research of Dr. Soma Sengupta, Dr. Claudia Rebola and Dr. Meera Rastogi, who have developed an art therapy app and pet robot study to see how the interventions can affect the mental health of patients with vestibular schwannomas.